Cash & equivalents increased 38.1%
Cash & equivalents changed +38.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +38.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross margin changed +349 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +25.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +50.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +20.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -29.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -250 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed +17.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Inventory changed +11.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -7.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Net income changed -1.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.